1.
AF Remacha, JF Nomdedeu, G Puget, C Estivill, MP Sarda, C Canals, A Aventin. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica 2006;91(5):719-720; https://doi.org/10.3324/%x.